pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Insomnia Drugs Market Report 2017


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 119 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

EMEA (Europe, Middle East and Africa) Insomnia Drugs Market Report 2017
1 Insomnia Drugs Overview
1.1 Product Overview and Scope of Insomnia Drugs
1.2 Classification of Insomnia Drugs
1.2.1 EMEA Insomnia Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Insomnia Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Tablets
1.2.4 Capsules
1.3 EMEA Insomnia Drugs Market by Application/End Users
1.3.1 EMEA Insomnia Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Adults
1.3.3 Children
1.4 EMEA Insomnia Drugs Market by Region
1.4.1 EMEA Insomnia Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insomnia Drugs (2012-2022)
1.5.1 EMEA Insomnia Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Insomnia Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Insomnia Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Insomnia Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Insomnia Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Insomnia Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Insomnia Drugs Sale Price by Players (2012-2017)
2.2 EMEA Insomnia Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Insomnia Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Insomnia Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Insomnia Drugs Sale Price by Type (2012-2017)
2.3 EMEA Insomnia Drugs (Volume) by Application
2.4 EMEA Insomnia Drugs (Volume and Value) by Region
2.4.1 EMEA Insomnia Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Insomnia Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Insomnia Drugs Sales Price by Region (2012-2017)

3 Europe Insomnia Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Insomnia Drugs Sales and Value (2012-2017)
3.1.1 Europe Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Insomnia Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Insomnia Drugs Sales and Market Share by Type
3.3 Europe Insomnia Drugs Sales and Market Share by Application
3.4 Europe Insomnia Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Insomnia Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Insomnia Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Insomnia Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Insomnia Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Insomnia Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Insomnia Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Insomnia Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Insomnia Drugs Sales and Growth Rate (2012-2017)

4 Middle East Insomnia Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Insomnia Drugs Sales and Value (2012-2017)
4.1.1 Middle East Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Insomnia Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Insomnia Drugs Sales and Market Share by Type
4.3 Middle East Insomnia Drugs Sales and Market Share by Application
4.4 Middle East Insomnia Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Insomnia Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Insomnia Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Insomnia Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Insomnia Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Insomnia Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Insomnia Drugs Sales and Growth Rate (2012-2017)

5 Africa Insomnia Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Insomnia Drugs Sales and Value (2012-2017)
5.1.1 Africa Insomnia Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Insomnia Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Insomnia Drugs Sales and Market Share by Type
5.3 Africa Insomnia Drugs Sales and Market Share by Application
5.4 Africa Insomnia Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Insomnia Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Insomnia Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Insomnia Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Insomnia Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Insomnia Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Insomnia Drugs Sales and Growth Rate (2012-2017)

6 EMEA Insomnia Drugs Manufacturers/Players Profiles and Sales Data
6.1 Eisai
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insomnia Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Eisai Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Insomnia Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Insomnia Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Insomnia Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Takeda
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Insomnia Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Takeda Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Astellas
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Insomnia Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Astellas Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biocodex
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Insomnia Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocodex Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Dainippon Sumitomo
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Insomnia Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Dainippon Sumitomo Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 ECR Pharmaceuticals
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Insomnia Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 ECR Pharmaceuticals Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Fidia Farmaceutici
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Insomnia Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Fidia Farmaceutici Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Flynn Pharma
6.12 Johnson & Johnson
6.13 Juste
6.14 Meda
6.15 Pernix Therapeutics
6.16 Purdue Pharma
6.17 Vanda Pharmaceuticals

7 Insomnia Drugs Manufacturing Cost Analysis
7.1 Insomnia Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insomnia Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Insomnia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insomnia Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Insomnia Drugs Market Forecast (2017-2022)
11.1 EMEA Insomnia Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Insomnia Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Insomnia Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Insomnia Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Insomnia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Insomnia Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Insomnia Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Back To Top